Sandipan Shringi

Dyslipidemia and Kidney Stone Risk: Mechanisms, Clinical Evidence, and Therapeutic Considerations

The prevalence of kidney stone (KS) disease and cardiometabolic diseases are simultaneously increasing in the United States. Dyslipidemia has been associated with an increased risk for KS formation and recurrence due to alterations in metabolism of purine and oxalate along with a...